77 related articles for article (PubMed ID: 29794791)
41. A general framework for weighted gene co-expression network analysis.
Zhang B; Horvath S
Stat Appl Genet Mol Biol; 2005; 4():Article17. PubMed ID: 16646834
[TBL] [Abstract][Full Text] [Related]
42. Array comparative genomic hybridization and its applications in cancer.
Pinkel D; Albertson DG
Nat Genet; 2005 Jun; 37 Suppl():S11-7. PubMed ID: 15920524
[TBL] [Abstract][Full Text] [Related]
43. The pathogenesis of mycosis fungoides.
Girardi M; Heald PW; Wilson LD
N Engl J Med; 2004 May; 350(19):1978-88. PubMed ID: 15128898
[No Abstract] [Full Text] [Related]
44. A gene-coexpression network for global discovery of conserved genetic modules.
Stuart JM; Segal E; Koller D; Kim SK
Science; 2003 Oct; 302(5643):249-55. PubMed ID: 12934013
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study.
Karenko L; Sarna S; Kähkönen M; Ranki A
Br J Dermatol; 2003 Jan; 148(1):55-64. PubMed ID: 12534595
[TBL] [Abstract][Full Text] [Related]
47. IL-17: prototype member of an emerging cytokine family.
Aggarwal S; Gurney AL
J Leukoc Biol; 2002 Jan; 71(1):1-8. PubMed ID: 11781375
[TBL] [Abstract][Full Text] [Related]
48. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.
Hymowitz SG; Filvaroff EH; Yin JP; Lee J; Cai L; Risser P; Maruoka M; Mao W; Foster J; Kelley RF; Pan G; Gurney AL; de Vos AM; Starovasnik MA
EMBO J; 2001 Oct; 20(19):5332-41. PubMed ID: 11574464
[TBL] [Abstract][Full Text] [Related]
49. Hypercalcemia and parathyroid hormone related protein expression in cutaneous T-cell lymphoma.
Obagi S; Derubertis F; Brown L; Deng JS
Int J Dermatol; 1999 Nov; 38(11):855-62. PubMed ID: 10583622
[No Abstract] [Full Text] [Related]
50. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.
Weinstock MA; Gardstein B
Am J Public Health; 1999 Aug; 89(8):1240-4. PubMed ID: 10432915
[TBL] [Abstract][Full Text] [Related]
51. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
[TBL] [Abstract][Full Text] [Related]
52. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation.
Van Dam J; Rice TW; Catalano MF; Kirby T; Sivak MV
Cancer; 1993 May; 71(10):2910-7. PubMed ID: 8490818
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Kim YH; Bishop K; Varghese A; Hoppe RT
Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
[TBL] [Abstract][Full Text] [Related]
54. Immune specific induction of interferon production in cultures of human blood lymphocytes.
Green JA; Cooperband SR; Kibrick S
Science; 1969 Jun; 164(3886):1415-7. PubMed ID: 5783715
[TBL] [Abstract][Full Text] [Related]
55. T. Duckett Jones and his association with Paul Dudley White.
Paul O; Bland EF; Massell BF
Clin Cardiol; 1990 May; 13(5):367-9. PubMed ID: 2189615
[No Abstract] [Full Text] [Related]
56. Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides.
Dong Z; Zhu X; Li Y; Gan L; Chen H; Zhang W; Sun J
Medicine (Baltimore); 2018 May; 97(21):e10871. PubMed ID: 29794791
[TBL] [Abstract][Full Text] [Related]
57. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
58. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).
Bunn PA; Foss FM
J Cell Biochem Suppl; 1996; 24():12-23. PubMed ID: 8806090
[TBL] [Abstract][Full Text] [Related]
59. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
60. Early-stage mycosis fungoides variants: case-based review.
Cho-Vega JH; Tschen JA; Duvic M; Vega F
Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
